Publisher's Comment.

J Biocommun

Association of Medical Illustrators.

Published: February 2016

JBC issue 40-1 represents a landmark publication for the Journal of Biocommunication, in that it is our first issue designed for JBC's new mixed publishing (hybrid) format. 
This issue combines traditionally licensed/copyrighted content with content published with open-access (OA) Creative Commons licensing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139012PMC
http://dx.doi.org/10.5210/jbc.v40i1.6622DOI Listing

Publication Analysis

Top Keywords

publisher's comment
4
comment jbc
4
jbc issue
4
issue 40-1
4
40-1 represents
4
represents landmark
4
landmark publication
4
publication journal
4
journal biocommunication
4
biocommunication issue
4

Similar Publications

Comment on "Stability and degradation mechanism of (-)-epicatechin in thermal processing".

Food Chem

January 2025

Poznań University of Technology, Institute of Chemistry and Technical Electrochemistry, Berdychowo 4, 60-965 Poznań, Poland. Electronic address:

Catechins, due to their high antioxidant capacity, are ones of the most common ingredients of human diet (e.g. tea, fruits, cacao) of the well-known health benefit properties.

View Article and Find Full Text PDF

Flurpiridaz F 18: First Approval.

Am J Cardiovasc Drugs

January 2025

Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.

Flurpiridaz F 18 (FLYRCADO™) is an intravenous (IV) radioactive diagnostic drug being developed by GE Healthcare and Lantheus Medical Imaging for use in positron emission tomography (PET) myocardial perfusion imaging (MPI) to detect coronary artery disease (CAD). In September 2024, flurpiridaz F 18 was approved in the USA for PET MPI under rest or stress (pharmacologic or exercise) in adult patients with known or suspected CAD to evaluate for myocardial ischemia and infarction. This article summarizes the milestones in the development of flurpiridaz F 18 leading to this first approval for use in PET MPI in adult patients to evaluate for myocardial ischemia and infarction.

View Article and Find Full Text PDF

Clinical presentation of celiac disease in adult patients: current real‑life experience: comment.

Intern Emerg Med

January 2025

Unit of Internal Medicine, Department of Medical Sciences, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Foggia, Italy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!